The global Vitamin K2 market is expected to develop at a CAGR of 7.1 percent (2021-2028). Factors such as rising demand for healthy foods and supplements, rising cases of cardiovascular disease and osteoporosis, and a rise in the global elderly population base will all contribute to the growth.
Vitamin K is a fat-soluble vitamin that aids in the coagulation of blood. Vitamin K is necessary for bone health and the prevention of osteoporosis. Vitamin K (K0) and Vitamin K (K1) are the two subtypes (K). Although their attributes differ depending on the type, both types have synthetic forms. Phylloquinone (K) and menaquinone (M) are the most relevant variations in this context (MK-n).
List of Key Companies Covered in this report:
- Kappa Bioscience (Norway)
- Lesaffre (France)
- Viridis BioPharma (India)
- Seebio Biotech (Shanghai) Co.,Ltd (China)
- DSM (Netherlands)
- International Flavors Fragrances Inc. (US)
- Kyowa Hakko Bio Co. Ltd (Japan)
- Purayati (India)
- Vox Nutrition (US)
- Anderson Global Group, LLC. (US)
Based on Type, the Vitamin K2 Market is segmented into MK-4, MK-7, Other.
MK-seven is a vitamin K subtype. Menaquinone (shortened MK-n or MenaQ) is another name (the q means quinine). This is required for the production of prothrombin within the body. Since vitamin K is involved in blood clotting, a vitamin K shortage can induce bleeding difficulties.
MK-4 is a kind of Vitamin K that is found in animal tissues naturally. This is sold as a dietary supplement to treat osteoporosis, diabetes-related eye problems, vitamin D deficiency, bone fractures, and age-related macular degeneration (AMD).
The market is divided into Powder and Oil segments based on application.
Vitamin K is a powdered vitamin that is used to treat excessive calcium levels. The vitamin assists your body to absorb less calcium, which might minimize your risk of developing osteoporosis or kidney stones. Vitamin K is also used to stop and slow bleeding caused by blood-thinning drugs (anticoagulants) like warfarin.
Vitamin K is mostly available in supplements. However, it can also be found in dietary oils for cooking. Plants that produce vitamin K oil are produced on terrain that is rich in particular minerals and nutrients. Plants can create more vitamins within that type of soil than they could if they were growing in a nutrient-deficient condition.
The function of vitamins in general health and their benefits on the human body, particularly bones, is well supported by clinical research. Vitamin k-based goods, such as injection form (pharmaceutical grade), food fortification, oral supplements, and dietary supplements, will benefit from this aspect. Because of the rising demand for vitamin supplements, the worldwide Vitamin K market is likely to rise significantly over the forecast period.
Vitamin K injections, which are more expensive than other kinds of vitamin supplementation, could manage vitamin K deficiency. Over the projected period, this aspect will restrain the growth of the Vitamin K injection market. The market for vitamin K, on the other hand, is predicted to rise due to the rising demand for organic foods, which encompasses dairy products.
North America is the greatest market shareholder in 2019, followed by Europe and the Asia Pacific. Within the next 5 years, the demand for vitamin K2 in the Asia Pacific is projected to increase due to a significant increase in the consumption of functional foods by inhabitants of Australia, India, and China. Because of the government's ongoing health and wellness efforts, the Middle East and Africa are likely to have a moderate demand for vitamin K2.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America